Skip to main content

BioNTech’s stock rallies after it posts surprise Q3 profit and revenue that tops estimates

BioNTech SE beat estimates, despite lower COVID-19 vaccine revenue.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.